Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Current Deferred Revenue (2023 - 2026)

Hinge Health's Current Deferred Revenue history spans 3 years, with the latest figure at $300.9 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 38.24% to $300.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $300.9 million, a 38.24% increase, with the full-year FY2025 number at $300.9 million, up 38.24% from a year prior.
  • Current Deferred Revenue hit $300.9 million in Q4 2025 for Hinge Health, roughly flat from $299.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for HNGE hit a ceiling of $300.9 million in Q4 2025 and a floor of $140.5 million in Q4 2023.
  • Historically, Current Deferred Revenue has averaged $233.0 million across 3 years, with a median of $217.6 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: surged 54.93% in 2024 and later soared 38.24% in 2025.
  • Tracing HNGE's Current Deferred Revenue over 3 years: stood at $140.5 million in 2023, then skyrocketed by 54.93% to $217.6 million in 2024, then soared by 38.24% to $300.9 million in 2025.
  • Business Quant data shows Current Deferred Revenue for HNGE at $300.9 million in Q4 2025, $299.7 million in Q3 2025, and $275.1 million in Q2 2025.